Reglan Resources

Reglan Drug Injury

FDA Warnings

In February 2009, the Food and Drug Administration (FDA) issued a warning about metoclopramide, stating that chronic use of the drug has been linked to tardive dyskinesia, which may include involuntary and repetitive movements of the body, even after the drugs are no longer taken. The FDA statement explained that patients and health care professionals should know about this risk so they can make informed decisions about treatment.

If you believe that you or someone you love has tardive dyskinesia caused from Reglan®, contact the injury lawyers of Hughes & Coleman, who have experience in Reglan cases. Below are some additional resources for more information on Reglan movement disorders.

Reglan Resources

Bachmann-Strauss Dystonia & Parkinson Foundation
Fred French Building
551 Fifth Avenue, Suite 520
New York, NY 10176
212-682-9900
Website: www.dystonia-parkinsons.org

Care4Dystonia, Inc.
c/o Serdans, RN, MS, NP
440 East 78th Street
New York, NY 10075
Website: www.care4dystonia.org

Dystonia Medical Research Foundation
One East Wacker Drive, Suite 2810
Chicago, IL 60601-1905
312-755-0198; toll free: 800-377-DYST (3978)
E-mail: dystonia@dystonia-foundation.org
Website: www.dystonia-foundation.org

The Movement Disorder Society
555 East Wells Street, Suite 1100
Milwaukee, WI 53202-3823
414-276-2145
E-mail: info@movementdisorders.org
Website: www.movementdisorders.org

National Spasmodic Dysphonia Association
300 Park Blvd; Suite 301
Itasca, IL 60143
800-795-NSDA (6732)
E-mail: NSDA@dysphonia.org
Website: www.dysphonia.org

WE MOVE
204 West 84th Street
New York, NY 10024
E-mail: wemove@wemove.org
Website: www.wemove.org